BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6181287)

  • 1. The pathophysiologic role of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    Klin Wochenschr; 1982 Jul; 60(14):713-6. PubMed ID: 6181287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic and surgical modulation of myocardial depressant factor formation and action during shock.
    Lefer AM
    Prog Clin Biol Res; 1983; 111():111-23. PubMed ID: 6191336
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock.
    Lefer AM
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R193-205. PubMed ID: 3544878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of the myocardial depressant factor in the pathogenesis of the shock].
    Pagni E
    Minerva Anestesiol; 1980 Sep; 46(9):1001-32. PubMed ID: 7012671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive feedback actions of a myocardial depressant factor in circulatory shock.
    Lefer AM
    Tex Rep Biol Med; 1979; 39():209-16. PubMed ID: 553307
    [No Abstract]   [Full Text] [Related]  

  • 6. MDF: its participation in the pathophysiology of shock.
    Okada K; Kosugi I; Tanokura Y; Tajimi K; Ohmura A; Innami H; Tsukamoto T; Inaba T
    Prog Clin Biol Res; 1983; 111():125-46. PubMed ID: 6867021
    [No Abstract]   [Full Text] [Related]  

  • 7. Current concepts on myocardial depressant factor.
    Giuseppe T; Marco S; Sigfrido I; Pasquale M; Giorgio C
    Mater Med Pol; 1989; 21(1):53-6. PubMed ID: 2699345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms that inhibit the formation and manifestation of the myocardial depressant factor in shock states].
    Lefer AM
    Khirurgiia (Sofiia); 1980; 33(5):377-85. PubMed ID: 7003214
    [No Abstract]   [Full Text] [Related]  

  • 9. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM; Tabas J; Smith EF
    Pharmacology; 1980; 21(3):206-12. PubMed ID: 6997895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective actions of aprotinin in acute traumatic shock.
    Araki H; Lefer AM
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the splanchnic visceral organs in development of tolerance to traumatic shock.
    Araki H; Sollott SJ; Lefer AM
    J Trauma; 1980 Dec; 20(12):1046-51. PubMed ID: 7452749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of shock.
    Okada K; Kosugi I; Kitagaki T; Yamaguchi Y; Yoshikawa H
    Jpn Circ J; 1977 Apr; 41(4):346-61. PubMed ID: 875220
    [No Abstract]   [Full Text] [Related]  

  • 13. The myocardial depressant factor (MDF) in acute hemorrhagic pancreatitis.
    Ito K; Ramirez-Schon G; Shah PM; DelGuercio LR; Reynolds BM
    Trans Am Soc Artif Intern Organs; 1980; 26():149-52. PubMed ID: 7245473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humoral factors in shock causing bradycardia and myocardial depression.
    David D; Hilewitz H; Rogel S
    Circ Shock; 1977; 4(2):153-61. PubMed ID: 21757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic hypoperfusion and the production of a myocardial depressant factor in hemorrhagic shock.
    Lefer AM; Spath JA
    Ann Surg; 1974 Jun; 179(6):868-76. PubMed ID: 4835505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of cardioinhibitory factors produced in shock.
    Lefer AM
    Fed Proc; 1978 Nov; 37(13):2734-40. PubMed ID: 361437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiological effect of myocardial depressant factor (author's transl)].
    Kosugi I; Yamaguchi Y; Okada K
    Kokyu To Junkan; 1975 Sep; 23(9):805-10. PubMed ID: 1239066
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current status of the myocardial depressant factor (MDF) and shock].
    Favaro R; Pelaia P
    Minerva Anestesiol; 1979; 45(7-8):594-600. PubMed ID: 548819
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological modulation of myocardial depressant factor as a mediator of circulatory shock.
    Lefer AM
    J Chemother; 1989 Jul; 1(4 Suppl):469-72. PubMed ID: 16312489
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.